Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
J Med Internet Res ; 24(7): e36996, 2022 07 27.
Article in English | MEDLINE | ID: covidwho-1963254

ABSTRACT

BACKGROUND: Telemedicine can help mitigate important health care challenges, such as demographic changes and the current COVID-19 pandemic, in high-income countries such as Germany. It gives physicians and patients the opportunity to interact via video consultations, regardless of their location, thus offering cost and time savings for both sides. OBJECTIVE: We aimed to investigate whether telemedicine can be implemented efficiently in the follow-up care for patients in orthopedic and trauma surgery, with respect to patient satisfaction, physician satisfaction, and quality of care. METHODS: We conducted a prospective randomized controlled trial in a German university hospital and enrolled 60 patients with different knee and shoulder conditions. For follow-up appointments, patients received either an in-person consultation in the clinic (control group) or a video consultation with their physician (telemedicine group). Patients' and physicians' subsequent evaluations of these follow-up appointments were collected and assessed using separate questionnaires. RESULTS: On the basis of data from 52 consultations after 8 withdrawals, it was found that patients were slightly more satisfied with video consultations (mean 1.58, SD 0.643) than with in-clinic consultations (mean 1.64, SD 0.569), although the difference was not statistically significant (P=.69). After excluding video consultations marred by technical problems, no significant difference was found in physician satisfaction between the groups (mean 1.47, SD 0.516 vs mean 1.32, SD 0.557; P=.31). Further analysis indicated that telemedicine can be applied to broader groups of patients and that patients who have prior experience with telemedicine are more willing to use telemedicine for follow-up care. CONCLUSIONS: Telemedicine can be an alternative and efficient form of follow-up care for patients in orthopedic and trauma surgery in Germany, and it has no significant disadvantages compared with in-person consultations in the clinic. TRIAL REGISTRATION: German Clinical Trials Register DRKS00023445; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023445.


Subject(s)
Aftercare/methods , COVID-19 , Orthopedic Procedures/standards , Telemedicine/standards , Wounds and Injuries/surgery , Aftercare/standards , COVID-19/epidemiology , COVID-19/prevention & control , Germany , Humans , Pandemics/prevention & control , Patient Satisfaction , Prospective Studies , Referral and Consultation/classification , Referral and Consultation/standards , Referral and Consultation/trends , Telemedicine/methods , Videoconferencing/standards
3.
Plast Reconstr Surg ; 147(5): 872e-874e, 2021 05 01.
Article in English | MEDLINE | ID: covidwho-1198273

ABSTRACT

SUMMARY: The 2020 global pandemic related to the coronavirus has led to unprecedented interruptions in typical patient care and resident education. Teleconferencing software was deployed by many institutions to comply with quarantine and social-distancing regulations. To supplement the loss of clinical experience for trainees, the authors implemented a novel virtual-educational programming using virtual visiting professors and virtual grand rounds. The authors describe the two different formats and advantages such as access to multiple speakers on diverse, innovative topics and decreased financial burdens to the host program. However, the authors do acknowledge some disadvantages from lack of face-to-face social interaction/networking and the need to consider time-zone differences. Both new programs were embraced by trainees at the authors' own institution and residents/medical students across the United States and Canada and around the world. The authors believe teleconferencing should be permanently incorporated into future educational opportunities for plastic surgeons, as it provides easy access to high-quality information.


Subject(s)
COVID-19/prevention & control , Internship and Residency/organization & administration , Teaching Rounds/organization & administration , Videoconferencing/organization & administration , COVID-19/epidemiology , COVID-19/transmission , Canada , Faculty , Humans , Internship and Residency/economics , Internship and Residency/standards , Pandemics/prevention & control , Students, Medical , Surgeons , Teaching Rounds/economics , Teaching Rounds/standards , United States , Videoconferencing/standards
5.
Psychol Psychother ; 94(3): 854-883, 2021 09.
Article in English | MEDLINE | ID: covidwho-1096921

ABSTRACT

PURPOSE: The COVID-19 pandemic has resulted in a widespread adoption of videoconferencing as a communication medium in mental health service delivery. This review considers the empirical literature to date on using videoconferencing to deliver psychological therapy to adults presenting with mental health problems. METHOD: Papers were identified via search of relevant databases. Quantitative and qualitative data were extracted and synthesized on uptake, feasibility, outcomes, and participant and therapist experiences. RESULTS: Videoconferencing has an established evidence base in the delivery of cognitive behavioural therapies for post-traumatic stress disorder and depression, with prolonged exposure, cognitive processing therapy, and behavioural activation non-inferior to in-person delivery. There are large trials reporting efficacy for health anxiety and bulimia nervosa compared with treatment-as-usual. Initial studies show applicability of cognitive behavioural therapies for other anxiety and eating disorders and obsessive-compulsive spectrum disorders, but there has yet to be study of use in severe and complex mental health problems. Therapists may find it more difficult to judge non-verbal behaviour, and there may be initial discomfort while adapting to videoconferencing, but client ratings of the therapeutic alliance are similar to in-person therapy, and videoconferencing may have advantages such as being less confronting. There may be useful opportunities for videoconferencing in embedding therapy delivery within the client's own environment. CONCLUSIONS: Videoconferencing is an accessible and effective modality for therapy delivery. Future research needs to extend beyond testing whether videoconferencing can replicate in-person therapy delivery to consider unique therapeutic affordances of the videoconferencing modality. PRACTITIONER POINTS: Videoconferencing is an efficacious means of delivering behavioural and cognitive therapies to adults with mental health problems. Trial evidence has established it is no less efficacious than in-person therapy for prolonged exposure, cognitive processing therapy, and behavioural activation. While therapists report nonverbal feedback being harder to judge, and clients can take time to adapt to videoconferencing, clients rate the therapeutic alliance and satisfaction similarly to therapy in-person. Videoconferencing provides opportunities to integrate therapeutic exercises within the person's day-to-day environment.


Subject(s)
Behavior Therapy/standards , Mental Disorders/therapy , Patient Satisfaction , Process Assessment, Health Care , Telemedicine/standards , Therapeutic Alliance , Videoconferencing/standards , COVID-19/prevention & control , Humans
6.
J Med Internet Res ; 23(1): e23775, 2021 01 26.
Article in English | MEDLINE | ID: covidwho-1024475

ABSTRACT

BACKGROUND: COVID-19 has thrust video consulting into the limelight, as health care practitioners worldwide shift to delivering care remotely. Evidence suggests that video consulting is acceptable, safe, and effective in selected conditions and settings. However, research to date has mostly focused on initial adoption, with limited consideration of how video consulting can be mainstreamed and sustained. OBJECTIVE: This study sought to do the following: (1) review and synthesize reported opportunities, challenges, and lessons learned in the scale-up, spread, and sustainability of video consultations, and (2) identify transferable insights that can inform policy and practice. METHODS: We identified papers through systematic searches in PubMed, CINAHL, and Web of Science. Included articles reported on synchronous, video-based consultations that had spread to more than one setting beyond an initial pilot or feasibility stage, and were published since 2010. We used the Nonadoption, Abandonment, and challenges to the Scale-up, Spread, and Sustainability (NASSS) framework to synthesize findings relating to 7 domains: an understanding of the health condition(s) for which video consultations were being used, the material properties of the technological platform and relevant peripherals, the value proposition for patients and developers, the role of the adopter system, organizational factors, wider macro-level considerations, and emergence over time. RESULTS: We identified 13 papers describing 10 different video consultation services in 6 regions, covering the following: (1) video-to-home services, connecting providers directly to the patient; (2) hub-and-spoke models, connecting a provider at a central hub to a patient at a rural center; and (3) large-scale top-down evaluations scaled up or spread across a national health administration. Services covered rehabilitation, geriatrics, cancer surgery, diabetes, and mental health, as well as general specialist care and primary care. Potential enablers of spread and scale-up included embedded leadership and the presence of a telehealth champion, appropriate reimbursement mechanisms, user-friendly technology, pre-existing staff relationships, and adaptation (of technology and services) over time. Challenges tended to be related to service development, such as the absence of a long-term strategic plan, resistance to change, cost and reimbursement issues, and the technical experience of staff. There was limited articulation of the challenges to scale-up and spread of video consultations. This was combined with a lack of theorization, with papers tending to view spread and scale-up as the sum of multiple technical implementations, rather than theorizing the distinct processes required to achieve widespread adoption. CONCLUSIONS: There remains a significant lack of evidence that can support the spread and scale-up of video consulting. Given the recent pace of change due to COVID-19, a more definitive evidence base is urgently needed to support global efforts and match enthusiasm for extending use.


Subject(s)
COVID-19/epidemiology , Delivery of Health Care/standards , Telemedicine/methods , Videoconferencing/standards , Humans , Pandemics , Primary Health Care/organization & administration , SARS-CoV-2/isolation & purification
7.
JCO Oncol Pract ; 17(1): e26-e35, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1024379

ABSTRACT

PURPOSE: Approximately 20% of caregivers (CGs) live > 1 hour away from the patient and are considered distance caregivers (DCGs) who often report higher distress and anxiety than local CGs. The purpose of this study was to test the effectiveness of an intervention aimed at reducing anxiety and distress in DCGs of patients with cancer. METHODS: This randomized controlled trial enrolled DCGs of patients with all cancer types who were being seen monthly by oncologists in outpatient clinics. There were three arms of the intervention delivered over a 4-month period: arm 1 (a) received 4 monthly videoconference-tailored coaching sessions with an advanced practice nurse or social worker focused on information and support, (b) participated in patient's appointments with the oncologist via videoconference over the 4-month study period, and (c) had access to a website designed for DCGs. Arm 2 did not receive the coaching sessions but received the other two components, and arm 3 received access to the DCG website only. RESULTS: There were 302 DCGs who provided pre- and postintervention data. There were significant anxiety by group (P = .028 and r = 0.16) and distress by group interactions (P = .014 and r = 0.17). Arm 1 had the greatest percentage of DCGs who demonstrated improvement in anxiety (18.6%) and distress (25.2%). CONCLUSION: Coaching and use of videoconference technology (to join the DCG into the patient-oncologist office visit) were effective in reducing both anxiety and distress for DCGs. These components could be considered for local CGs who-with COVID-19-are unable to accompany the patient to oncologist visits.


Subject(s)
Anxiety Disorders/psychology , COVID-19/psychology , Caregivers/psychology , Neoplasms/psychology , Adult , Anxiety Disorders/complications , Anxiety Disorders/pathology , Anxiety Disorders/therapy , COVID-19/complications , COVID-19/pathology , COVID-19/therapy , Cost-Benefit Analysis , Female , Humans , Male , Middle Aged , Neoplasms/complications , Neoplasms/pathology , Neoplasms/therapy , Oncologists , Quality of Life , SARS-CoV-2/pathogenicity , Surveys and Questionnaires , Videoconferencing/standards
9.
GMS J Med Educ ; 37(7): Doc99, 2020.
Article in English | MEDLINE | ID: covidwho-971676

ABSTRACT

Objective: COVID-19 challenges curriculum managers worldwide to create digital substitutes for classroom teaching. Case-based teaching formats under expert supervision can be used as a substitute for practical bedside teaching, where the focus is on teaching clinical reasoning skills. Methods: For medical students of LMU and TU Munich, the interactive, case-based, and supervised teaching format of Clinical Case Discussion (CCD) was digitised and implemented as dCCD in their respective curricula. Case discussions were realised as videoconferences, led by a student moderator, and took place under the supervision of a board-certified clinician. To prevent passive participation, additional cognitive activations were implemented. Acceptance, usability, and subjective learning outcomes were assessed in dCCDs by means of a special evaluation concept. Results: With regard to acceptance, students were of the opinion that they had learned effectively by participating in dCCDs (M=4.31; SD=1.37). The majority of students also stated that they would recommend the course to others (M=4.23; SD=1.62). The technical implementation of the teaching format was judged positively overall, but findings for usability were heterogeneous. Students rated their clinical reasoning skills at the end of the dCCDs (M=4.43; SD=0.66) as being significantly higher than at the beginning (M=4.33; SD=0.69), with low effect size, t(181)=-2.352, p=.020, d=0.15. Conclusion: Our evaluation data shows that the dCCD format is well-accepted by students as a substitute for face-to-face teaching. In the next step, we plan to examine the extent to which participation in dCCDs leads to an increase in objectively measured clinical reasoning skills, analogous to a face-to-face CCD with on-site attendance.


Subject(s)
COVID-19/epidemiology , Clinical Decision-Making/methods , Education, Distance/organization & administration , Education, Medical/organization & administration , Videoconferencing/organization & administration , Clinical Competence , Education, Distance/standards , Education, Medical/standards , Educational Measurement , Humans , Pandemics , SARS-CoV-2 , Students, Medical/psychology , Videoconferencing/standards
10.
Br J Hosp Med (Lond) ; 81(10): 1, 2020 Oct 02.
Article in English | MEDLINE | ID: covidwho-903016
11.
Scand J Pain ; 21(1): 32-40, 2021 01 27.
Article in English | MEDLINE | ID: covidwho-835987

ABSTRACT

OBJECTIVES: During the current COVID-19 pandemic, healthcare has been transformed by the rapid switch from in person care to use of remote consulting, including video conferencing technology. Whilst much has been published on one-to-one video consultations, little literature exists on use of this technology to facilitate group interventions. Group pain management programmes are a core treatment provided by many pain services. This rapid review aimed to identify the extent of use of video conferencing technology for delivery of group pain management programmes and provide an overview of its use. METHODS: A rapid review of the literature published up to April 2020 (PubMed, PsycINFO and PEDro) was performed. The search string consisted of three domains: pain/CP (MeSH term) AND Peer group[MeSH] AND Videoconferencing[MeSH]/Telemedicine[MeSH]/Remote Consultation[MeSH]. The studies were of poor methodological quality and study design, and interventions and chronic pain conditions were varied. RESULTS: Literature searching yielded three eligible papers for this review. All studies had low methodological quality and risk of bias. Heterogeneity and variability in outcome reporting did not allow any pooling of data. The results demonstrated that videoconferencing for delivery of group programmes is possible, yet there is little extant literature on how to develop, deliver and measure outcomes of such programmes. CONCLUSIONS: This review demonstrates that there is little evidence to support or guide the use of synchronous videoconferencing to deliver pain management programmes. We present issues to consider, informed by this review and our experience, when implementing video conferencing. Study quality of existing work is variable, and extensive future research is necessary.


Subject(s)
Chronic Pain/therapy , Pain Management , Telemedicine , Videoconferencing , Humans , Pain Management/standards , Telemedicine/standards , Videoconferencing/standards
13.
Ann Biol Clin (Paris) ; 78(3): 269-277, 2020 06 01.
Article in French | MEDLINE | ID: covidwho-608309

ABSTRACT

The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14th, the start of the planned containment exit from May 11th. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world: hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.


Subject(s)
Betacoronavirus , Biochemistry/organization & administration , Biomarkers/analysis , Clinical Laboratory Services/organization & administration , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Societies, Scientific/organization & administration , Betacoronavirus/isolation & purification , Betacoronavirus/pathogenicity , Biochemistry/standards , Biomarkers/blood , COVID-19 , Clinical Laboratory Services/standards , Community Networks/organization & administration , Community Networks/standards , Community Networks/trends , Coronavirus Infections/blood , Coronavirus Infections/epidemiology , Disease Outbreaks , France/epidemiology , History, 21st Century , Humans , Intersectoral Collaboration , Pandemics , Pneumonia, Viral/blood , Pneumonia, Viral/epidemiology , Professional Practice/organization & administration , Professional Practice/standards , Professional Practice/trends , SARS-CoV-2 , Societies, Scientific/standards , Videoconferencing/organization & administration , Videoconferencing/standards
16.
AIDS Behav ; 24(7): 1983-1989, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-30543

ABSTRACT

The novel coronavirus has upended many traditional research procedures as universities and other research entities have closed to activate social distancing. Some social and behavioral research activities (e.g. data analysis, manuscript preparation) can be continued from other environments with appropriate security protocols in place. For studies involving in-person interactions, continuity may be more difficult. Phone-based interactions provide a low-tech solution that may suffice in some cases. Yet, videoconferencing platforms can nearly replicate in-person interactions, activating both auditory and visual senses and potentially resulting in more substantial engagement. Staff can meet with participants individually or in groups, each seeing and hearing one another in real time. This paper provides guidance for researchers transitioning in-person assessments and interventions to a synchronous videoconferencing platform. Best practices, key considerations, examples from the field, and sample protocols are presented to ease transition for ongoing studies and maximize the potential of videoconferencing-and social distancing.


Subject(s)
COVID-19 , Coronavirus Infections , Pandemics , Pneumonia, Viral , Telemedicine/methods , Videoconferencing/standards , Betacoronavirus , COVID-19/epidemiology , COVID-19/prevention & control , Coronavirus , Coronavirus Infections/epidemiology , Humans , Physical Distancing , Pneumonia, Viral/epidemiology , Research Design , SARS-CoV-2 , Videoconferencing/organization & administration
SELECTION OF CITATIONS
SEARCH DETAIL